The current inflection point of pharmaceutical stocks has arrived! Many pharmaceutical companies such as Zai Lab and Junshi Biologics rose sharply
Time of Update: 2023-02-03
On the news, new data from the Stock Exchange shows that on December 22, JPMorgan Chase & Co. increased its holdings in Zai Lab again, buying about 13 million shares on the same day, and the proportion of good positions rose from 8.
K drug apocalypse: 13 innovative drugs give up medical insurance, still red flags flutter
Time of Update: 2023-01-05
2022 is a special year for Merck's PD-1 pembrolizumab (known as "K drug"). In 2022Q1, K drug surpassed Humira, the first blockbuster drug for ten consecutive years, with sales reaching US$4. 809 billi
Innovative medical devices will not be collected for the time being; CR and Fosun announced cooperation; 33 medical consumables face network withdrawal; The in vitro diagnostic sector is pulling up
Time of Update: 2022-10-19
The National Medical Insurance Administration also further clarified: for innovative products such as 3D printed orthopedic consumables, considering the characteristics of technical characteristics, production costs, usage, clinical efficacy and other characteristics, adopt the "one product and one policy" approach, determine appropriate procurement rules, improve the market-oriented price formation mechanism, promote the high-quality development of the medical device industry, and provide more innovative products for the people at reasonable prices.
Innovative drug companies and Chinese medicine companies have a large number of general managers leaving
Time of Update: 2022-10-03
Since the beginning of this year, the senior management of pharmaceutical companies has changed, and a large number of senior executives such as general managers of pharmaceutical companies have resigned for personal reasons, work adjustments and other reasons, and it has been particularly frequent since the second half of the year.
A batch of Chinese herbal medicine companies were "named
Time of Update: 2022-08-30
For example, on August 17, the Anhui Provincial Food and Drug Administration issued an announcement saying that 7 companies of Chinese herbal decoction pieces (including formula granules) had project defects, 5 of which rectified within a time limit, and 2 companies suspended production, admonished, and interviewed; August On the 11th, the Sichuan Food and Drug Administration issued a notice on 6 batches of drugs that did not meet the requirements.
Two sides of the coin: in the face of "soul bargaining", how to stimulate local pharmaceutical innovation
Time of Update: 2022-04-30
In recent years, in order not to delay the use of new drugs by patients, and at the same time reduce the uncertainty and risk of medical insurance payment, governments around the world have adopted more flexible and innovative access methods, which have achieved good results .
Domestic pharmaceutical companies are attacking innovative drugs, but these problems remain to be solved
Time of Update: 2022-03-06
In addition to Pien Tze Huang, many pharmaceutical companies have been increasing investment in the research and development of innovative drugs in recent years.
Kangyuan Pharmaceutical takes the lead in imitating GSK's best-selling migraine drug
Time of Update: 2021-12-04
Figure 1: The latest product status of Kangyuan Pharmaceutical Source: CDE official website Sumatriptan Naproxen Sodium Succinate Tablets is the first approved combination prescription preparation of triptans and anti-inflammatory analgesics, which relieve migraines through different pharmacological mechanisms of action .
Focusing on the research and development of a new generation of radiopharmaceuticals, this pharmaceutical company completed over 300 million yuan in financing
Time of Update: 2021-11-04
It can be seen that the capital market highly recognizes the strong nuclear drug innovation and research and development capabilities of Xiantong Pharmaceutical .
Under the accelerated transformation and upgrading of the pharmaceutical industry, how does the pharmaceutical machinery industry fight a "cooperation war
Time of Update: 2021-10-10
It is worth noting that in recent years, with the increasing aging of our country, the continuous improvement of residents' living standards, and the advancement of medical reform, the domestic pharmaceutical market has ushered in rapid development, while industrial transformation and upgrading have also begun to accelerate .
The third batch of national mining landed in November, the performance of pharmaceutical enterprises will be affected
Time of Update: 2020-11-05
For example, Huahai Pharmaceutical's net profit in the first half of this year increased by 72.77 percent year-on-year, one of the main reasons for the surge in net profit is that with the promotion of centralized procurement by the state, the company relies on the opportunity to expand the alliance region, product market coverage has been rapidly improved.
Kyusju Tong acquires step-by-step subsidiary to undertake prescription outflow
Time of Update: 2020-10-02
data show that Kyusju Tong, as the country's largest private pharmaceutical circulation enterprises, mainly to primary medical institutions pharmacies and private hospitals as the object, to provide drug sales and distribution services, so the company has a strong logistics and distribution capacity and terminal resources.
2020 Fortune China 500 list of 17 pharmaceutical companies listed among them
Time of Update: 2020-07-30
China's GDP exceeded 99 trillion yuan last year, meaning that the combined income of the top 500 listed companies is still more than half of China's GDP.
among the pharmaceutical companies on the list, China Pharmaceutical Holdings, Shanghai Pharma and China Resources Pharmaceuticals are among the top three.
Industry call: Drug test data protection system as soon as possible to "brighten" the innovation background
Time of Update: 2020-07-08
Recently, the closely watched two national conferences successfully closed According to the People's Daily, delegates made 9,180 recommendations during this year's congress, an increase of 1,020 from
MoshaDong, Takeda two major pharmaceutical companies in South Korea met with the various trade unions attacked
Time of Update: 2020-06-02
Medicine network August 7 - The basic duty of the trade union is to safeguard the legitimate rights and interests of workers, such as our Trade Union Law provides: "Trade union organizations on beha